Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

1.2

Margin Of Safety %

2

Put/Call OI Ratio

0.76

EPS Next Q Diff

0.24

EPS Last/This Y

-2.51

EPS This/Next Y

0.52

Price

134.32

Target Price

143.09

Analyst Recom

1.9

Performance Q

2.31

Relative Volume

1.39

Beta

0.73

Ticker: ABT




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02ABT133.60.801.17195939
2025-06-03ABT133.720.800.33198611
2025-06-04ABT132.960.800.85199889
2025-06-05ABT133.920.800.85200967
2025-06-06ABT133.530.790.67202001
2025-06-09ABT133.390.810.27197984
2025-06-10ABT134.160.790.43203603
2025-06-11ABT135.290.800.87204597
2025-06-12ABT136.390.800.67206744
2025-06-13ABT135.620.810.63208249
2025-06-16ABT1340.830.46203010
2025-06-17ABT132.260.830.54205272
2025-06-18ABT132.390.830.73207478
2025-06-20ABT133.050.830.44210604
2025-06-23ABT133.260.780.53158872
2025-06-24ABT138.080.780.36162990
2025-06-25ABT137.930.760.47171000
2025-06-26ABT133.670.771.26172146
2025-06-27ABT134.320.760.49173585
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02ABT133.609.52569.55.15
2025-06-03ABT133.719.52578.75.16
2025-06-04ABT132.979.52511.65.16
2025-06-05ABT133.949.52643.15.16
2025-06-06ABT133.539.52539.75.16
2025-06-09ABT133.409.52557.25.16
2025-06-10ABT134.179.52629.85.16
2025-06-11ABT135.299.52659.25.16
2025-06-12ABT136.459.52659.25.16
2025-06-13ABT135.629.52508.95.16
2025-06-16ABT133.999.52448.45.16
2025-06-17ABT132.269.62437.85.16
2025-06-18ABT132.419.62581.05.16
2025-06-20ABT132.999.62615.65.16
2025-06-23ABT133.279.62592.45.16
2025-06-24ABT138.079.62938.95.16
2025-06-25ABT137.459.62524.45.16
2025-06-26ABT133.609.62284.95.16
2025-06-27ABT134.329.62620.65.16
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02ABT-4.891.611.29
2025-06-03ABT-4.891.611.29
2025-06-04ABT-4.891.611.29
2025-06-05ABT-4.891.611.29
2025-06-06ABT-4.891.611.29
2025-06-09ABT-4.891.591.29
2025-06-10ABT-4.891.591.29
2025-06-11ABT-4.891.591.16
2025-06-12ABT-4.891.591.16
2025-06-13ABT-4.891.591.16
2025-06-16ABT-4.892.081.16
2025-06-17ABT-4.892.081.16
2025-06-18ABT-4.892.081.16
2025-06-20ABT-4.892.081.16
2025-06-23ABT-4.892.161.16
2025-06-24ABT-4.892.161.16
2025-06-25ABT-4.892.161.16
2025-06-26ABT-4.892.161.20
2025-06-27ABT-4.892.161.20
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

1.09

Avg. EPS Est. Current Quarter

1.25

Avg. EPS Est. Next Quarter

1.33

Insider Transactions

-4.89

Institutional Transactions

2.16

Beta

0.73

Average Sales Estimate Current Quarter

11011

Average Sales Estimate Next Quarter

11358

Fair Value

137.43

Quality Score

98

Growth Score

86

Sentiment Score

97

Actual DrawDown %

5.8

Max Drawdown 5-Year %

-33.9

Target Price

143.09

P/E

17.43

Forward P/E

23.62

PEG

1.68

P/S

5.52

P/B

4.79

P/Free Cash Flow

35.12

EPS

7.71

Average EPS Est. Cur. Y​

5.16

EPS Next Y. (Est.)

5.68

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

31.72

Relative Volume

1.39

Return on Equity vs Sector %

3.8

Return on Equity vs Industry %

9.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

2620.6
Abbott Laboratories
Sector: Healthcare
Industry: Medical Devices
Employees: 114000
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
stock quote shares ABT – Abbott Laboratories Stock Price stock today
news today ABT – Abbott Laboratories stock forecast ,stock prediction 2023 2024 2025
marketwatch ABT – Abbott Laboratories yahoo finance google finance
stock history ABT – Abbott Laboratories invest stock market
stock prices ABT premarket after hours
ticker ABT fair value insiders trading